Document is current
Any future updates will be listed below
-
Authors
Gujarathi, Rushabh
Belmont, Erika
Rodman, Christopher
Bansal, Varun Vivek
Setia, Namrata
Alpert, Lindsay
Hart, John
Möller, Mecker G.
Eng, Oliver S.
Lee, Grace
Chin, Janet
Amin, Manik A.
Polite, Blase N.
Liao, Chih-Yi
Turaga, Kiran K.
Shergill, Ardaman
- License Information
-
More Information
Article History
First Online: 14 June 2026
Ethics
Disclosure: Lindsay Alpert received consultant fees from Exact Sciences. Andy (Chih-Yi) Liao received honoraria from AstraZeneca, Exelixis, Genentech, Histosonics, Incyte, Ipsen, QED, Transthera, Boston Scientific, Taiho, and Exelixis. Ardaman Shergill received advisory and consultancy fees from Natera, Merus, Takeda, Ipson, Guardant, Pfizer, Amgen, Revolution Medicine, Iterion Therapeutics, Adcendo, and Abbvie; research (to institution) fees from Hutchison MediPharma/Takeda, Merck, Verastem Oncology, Turning Point Therapeutics, Gritstone, Bolt Therapeutics, BMS, Pfizer, Astellas, Oncologie, Macogenics, Seattle Genetics, Amgen, Daiichi, Eli Lilly, AstraZeneca, Genentech, Jazz Pharma, Abbvie, and Revmed; travel fees from Cure CRC Summit, Great Debates, OncLive, OSCO, ASCO, ACPMP, Cholangiocarcinoma Summit, Cholangiocarcinoma Foundation, ASCO Advantage, and Takeda for AACR poster.
